Collegium Pharmaceutical, Inc. (COLL) vs Faeth Therapeutics, Inc. (FTH)
A side-by-side comparison of Collegium Pharmaceutical, Inc. and Faeth Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COLL
Collegium Pharmaceutical, Inc.
$22.15HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
FTH
Faeth Therapeutics, Inc.
$26.56HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — COLL vs FTH
growth of $100 · dividends reinvested · last 6yCOLL -5.5% (-0.9%/yr)FTH -92.8% (-35.5%/yr)COLL compounded faster over this window
Log scale — wide-divergence pair
COLL FTH
COLL vs FTH: by the numbers
- •COLL is the larger company ($718M vs $685M market cap).
- •COLL is profitable (5.93% net margin) while FTH runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | COLL | FTH |
|---|---|---|
| P/E ratio | 17.86 | N/A |
| PEG ratio | 1.00 | N/A |
| P/S ratio | 0.89 | N/A |
| P/B ratio | 2.30 | 3.96 |
| EV / EBITDA | 2.86 | N/A |
| FCF yield | 45.70% | N/A |
Profitability
| Metric | COLL | FTH |
|---|---|---|
| Gross margin | 60.02% | 0.00% |
| Operating margin | 19.61% | 0.00% |
| Net margin | 5.93% | 0.00% |
| ROE | 15.36% | -113.05% |
| ROIC | 6.11% | -110.62% |
Growth (annualized)
| Metric | COLL | FTH |
|---|---|---|
| Revenue CAGR (5Y) | 19.91% | N/A |
| EPS CAGR (5Y) | 20.48% | N/A |
| FCF CAGR (5Y) | 26.38% | N/A |
| Total return CAGR (5Y) | 2.15% | -31.75% |
Frequently asked
- Is COLL or FTH more profitable?
- COLL runs the higher net margin — COLL at 5.93% versus FTH at 0.00%.
- How have COLL and FTH total returns compared?
- Over the past 5 years, COLL delivered 2.15% and FTH delivered -31.75% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Collegium Pharmaceutical P/E ratioCollegium Pharmaceutical ROEFaeth Therapeutics ROECollegium Pharmaceutical operating marginFaeth Therapeutics operating marginCollegium Pharmaceutical revenue growthFaeth Therapeutics revenue growthCollegium Pharmaceutical free cash flowFaeth Therapeutics free cash flow
Collegium Pharmaceutical & Faeth Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.